Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition

Shifa Jebari-Benslaiman1,2, Kepa B Uribe3, Asier Benito-Vicente1,2

  • 1Department of Molecular Biophysics, Biofisika Institute (University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC)), 48940 Leioa, Spain.

Biomedicines
|September 26, 2020
PubMed

Insights

The study found that dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) nanoparticles are most effective at removing excess cholesterol, a key factor in cardiovascular disease (CVD). These findings highlight the importance of nanoparticle composition for developing better CVD therapies.

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death, primarily driven by atherosclerosis.
  • Atherosclerosis involves the buildup of low-density lipoproteins in artery walls.
  • Reconstituted high-density lipoproteins (rHDLs) are being developed as therapies to remove excess cholesterol.

Purpose of the Study:

  • To evaluate the cholesterol efflux efficiency of rHDLs with varying lipid compositions.
  • To understand how lipid composition influences the effectiveness of cholesterol removal by rHDLs.
  • To mimic different in vivo high-density lipoprotein (HDL) maturation stages using rHDLs.

Main Methods:

  • Investigated cholesterol efflux activity of various rHDL formulations, including soybean PC (Soy-PC), DPPC, and combinations with cholesterol (Chol) and lysophosphatidylcholine (LysoPC).
  • Utilized multiple cell models to assess the impact of rHDL lipid composition on cholesterol removal.
  • Examined the role of the ABCA1 transporter in potentiating cholesterol efflux.

Main Results:

  • DPPC-based rHDLs demonstrated the highest efficiency in cholesterol efflux across all tested cellular models.
  • Cholesterol removal by DPPC rHDLs was enhanced when the ABCA1 transporter was upregulated.
  • The lipid composition significantly contributes to the effectiveness of cholesterol removal by rHDLs.

Conclusions:

  • DPPC rHDLs, resembling nascent HDL, are superior in inducing cholesterol efflux.
  • Enhanced efflux is attributed to cholesterol's binding affinity to saturated phospholipids and favorable bilayer curvature.
  • Physicochemical properties of rHDLs are critical for designing effective cholesterol-removing nanoparticles for CVD therapy.